Mupirocine Substipharm

Mupirocin, the active ingredient in Mupirocine Substipharm, is an antibiotic presented as a topical formulation for skin use. It is indicated for superficial bacterial skin infections such as impetigo, infected eczema and minor cuts at risk of infection. GNH USA supplies Mupirocine Substipharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocine Substipharm is a topical antibacterial that targets Gram‑positive skin pathogens. It is employed in the following clinical situations: - Impetigo: reduces bacterial load and promotes rapid healing of superficial lesions. - Secondary bacterial infections of the skin: controls colonising organisms and prevents spread. - Infected eczema: alleviates infection‑related inflammation and supports barrier recovery. - Minor cuts and abrasions with risk of infection: provides localized antimicrobial protection.

Mupirocine Substipharm is generally well tolerated when applied to intact skin, but local and systemic reactions can occur.

Common Side Effects: - Burning sensation at the application site. - Itching or mild pruritus. - Redness or erythema. - Dryness or peeling of the skin. - Stinging or tingling feeling. - Mild contact dermatitis.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, angioedema). - Extensive skin irritation or necrosis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic hypersensitivity with fever and malaise. - Drug‑induced liver injury (rare). - Acute generalized exanthematous pustulosis.

Before prescribing Mupirocine Substipharm, clinicians should consider the following safety points: - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown excretion; weigh benefits against potential risks. - Allergy: avoid in patients with known hypersensitivity to mupirocin or other topical antibiotics. - Extent of infection: limit to superficial skin lesions; do not use on deep or extensive wounds. - Pediatric use: safety documented in children; follow prescriber guidance. - Store at room temperature: keep in the original container, protect from moisture and light.

Mupirocine Substipharm has limited systemic drug interactions, but certain co‑applications may affect its efficacy or safety.

Major Interactions (Avoid): - Systemic antibiotics (e.g., oral penicillins): may diminish local antibacterial effect when large skin areas are treated. - Topical antiseptics containing alcohol or peroxide: can inactivate mupirocin on the skin.

Moderate Interactions (Monitor Closely): - Corticosteroid creams: may mask signs of infection and reduce local immune response. - Chemotherapeutic agents: increased risk of skin toxicity when combined. - Antifungal creams: potential for reduced antibacterial efficacy. - Other topical antibiotics: may increase risk of local irritation. - Occlusive dressings: can enhance systemic absorption, warranting observation.